Dirk Elewaut
UZ Ghent · University Hospital, Ghent · University Ghent
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Dirk Elewaut as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 22:40 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT04435288 · Spondyloarthritis: Inducing Drug-free Remission by Early TNF-alpha BlockadeUniversity Hospital, Ghent · active not recruiting · Peripheral Spondyloarthritis · principal investigator
- N/ANCT04261010 · TNF and IL23 Blocking Agents Gene Expression Ratios in the Psoriatic Arthritis Synovium_(TIGERS) StudyCliniques universitaires Saint-Luc- Université Catholique de Louvain · completed · Psoriatic Arthritis · principal investigator
- Ph3NCT03270501 · Efficacy of Golimumab in Early Axial Spondyloarthritis in Relation to Gut InflammationUniversity Ghent · completed · Axial Spondyloarthritis · principal investigator
- Ph2NCT02771860 · RANKL-blockade for the Treatment of Erosive Osteoarthritis (OA) of Interphalangeal Finger JointsUniversity Hospital, Ghent · completed · Hand Osteoarthritis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 22:40 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 22:40 UTC. The ranking covers the 200 most relevant of 17 PubMed records, and a shared surname and initials can bring in a namesake. All 17 on PubMed
- Adalimumab with or without methotrexate in juvenile rheumatoid arthritis.N Engl J Med · 2008426 citationsRCR 12.6
- Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomised trial on structure modification.Ann Rheum Dis · 2012163 citationsRCR 5.7
- Rituximab in diffuse cutaneous systemic sclerosis: an open-label clinical and histopathological study.Ann Rheum Dis · 2010162 citationsRCR 4.8
- Etanercept in patients with inflammatory hand osteoarthritis (EHOA): a multicentre, randomised, double-blind, placebo-controlled trial.Ann Rheum Dis · 2018145 citationsRCR 6.4
- Needle arthroscopy of the knee with synovial biopsy sampling: technical experience in 150 patients.Clin Rheumatol · 1999113 citationsRCR 2.8
- Anti-TNF-induced remission in very early peripheral spondyloarthritis: the CRESPA study.Ann Rheum Dis · 201758 citationsRCR 2.4
- RANKL blockade for erosive hand osteoarthritis: a randomized placebo-controlled phase 2a trial.Nat Med · 202457 citationsRCR 10.9
- Distinctive activated cellular subsets in colon from patients with Crohn's disease and ulcerative colitis.Scand J Gastroenterol · 199830 citationsRCR 0.7
- Altered expression of alpha E beta 7 integrin on intra-epithelial and lamina propria lymphocytes in patients with Crohn's disease.Acta Gastroenterol Belg · 199825 citationsRCR 0.5
- Short-term outcome of the second generation characterized chondrocyte implantation for the treatment of cartilage lesions in the knee.Knee Surg Sports Traumatol Arthrosc · 201224 citationsRCR 1.1